215 related articles for article (PubMed ID: 32279929)
1. HLA risk alleles and gut microbiome in ankylosing spondylitis and rheumatoid arthritis.
Xu H; Yin J
Best Pract Res Clin Rheumatol; 2019 Dec; 33(6):101499. PubMed ID: 32279929
[TBL] [Abstract][Full Text] [Related]
2. HLA Alleles Associated With Risk of Ankylosing Spondylitis and Rheumatoid Arthritis Influence the Gut Microbiome.
Asquith M; Sternes PR; Costello ME; Karstens L; Diamond S; Martin TM; Li Z; Marshall MS; Spector TD; le Cao KA; Rosenbaum JT; Brown MA
Arthritis Rheumatol; 2019 Oct; 71(10):1642-1650. PubMed ID: 31038287
[TBL] [Abstract][Full Text] [Related]
3. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis.
Jaakkola E; Herzberg I; Laiho K; Barnardo MC; Pointon JJ; Kauppi M; Kaarela K; Tuomilehto-Wolf E; Tuomilehto J; Wordsworth BP; Brown MA
Ann Rheum Dis; 2006 Jun; 65(6):775-80. PubMed ID: 16249228
[TBL] [Abstract][Full Text] [Related]
4. HLA alleles and HLA-B27 haplotypes associated with susceptibility and severity of ankylosing spondylitis in a Portuguese population.
Pimentel-Santos FM; Matos M; Ligeiro D; Mourão AF; Ribeiro C; Costa J; Santos H; Barcelos A; Pinto P; Cruz M; Sousa E; Santos RA; Fonseca JE; Trindade H; Guedes-Pinto H; Branco JC;
Tissue Antigens; 2013 Dec; 82(6):374-9. PubMed ID: 24498993
[TBL] [Abstract][Full Text] [Related]
5. [Two faces of an illness: rheumatoid arthritis followed by ankylosing spondylitis].
Varga E; Petró A; Jáger R; Varga L
Orv Hetil; 2009 Oct; 150(43):2000-3. PubMed ID: 19812023
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-microRNA interactions in ankylosing spondylitis.
Tavasolian F; Inman RD
Autoimmun Rev; 2021 Jun; 20(6):102827. PubMed ID: 33864943
[TBL] [Abstract][Full Text] [Related]
7. The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis: New insights and updates.
Babaie F; Hasankhani M; Mohammadi H; Safarzadeh E; Rezaiemanesh A; Salimi R; Baradaran B; Babaloo Z
Immunol Lett; 2018 Apr; 196():52-62. PubMed ID: 29409751
[TBL] [Abstract][Full Text] [Related]
8. The correlation between intestinal dysbiosis and the development of ankylosing spondylitis.
Zhang L; Hu Y; Xu Y; Li P; Ma H; Li X; Li M
Microb Pathog; 2019 Jul; 132():188-192. PubMed ID: 31039390
[TBL] [Abstract][Full Text] [Related]
9. Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome composition.
Yin J; Sternes PR; Wang M; Song J; Morrison M; Li T; Zhou L; Wu X; He F; Zhu J; Brown MA; Xu H
Ann Rheum Dis; 2020 Jan; 79(1):132-140. PubMed ID: 31662318
[TBL] [Abstract][Full Text] [Related]
10. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases.
Dequeker J; Decock T; Walravens M; Van de Putte I
J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494
[TBL] [Abstract][Full Text] [Related]
11. Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis.
Ben Radhia K; Ayed-Jendoubi S; Sfar I; Ben Romdhane T; Makhlouf M; Gorgi Y; Ayed K
Joint Bone Spine; 2008 Mar; 75(2):172-5. PubMed ID: 18329312
[TBL] [Abstract][Full Text] [Related]
12. Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.
Wen C; Zheng Z; Shao T; Liu L; Xie Z; Le Chatelier E; He Z; Zhong W; Fan Y; Zhang L; Li H; Wu C; Hu C; Xu Q; Zhou J; Cai S; Wang D; Huang Y; Breban M; Qin N; Ehrlich SD
Genome Biol; 2017 Jul; 18(1):142. PubMed ID: 28750650
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of HLA-A, -B, -Cw and DRB1 antigens in Moroccan patients with ankylosing spondylitis and a comparison of clinical features with frequencies of HLA-B*27.
El Mouraghi I; Ouarour A; Ghozlani I; Collantes E; Solana R; El Maghraoui A
Tissue Antigens; 2015 Feb; 85(2):108-16. PubMed ID: 25626601
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of HLA-B27 ankylosing spondylitis and DR4 seropositive nodular rheumatoid arthritis in patient with membranous nephropathy.
Lemmer JP; Irby WR
J Rheumatol; 1981; 8(4):661-4. PubMed ID: 6975378
[TBL] [Abstract][Full Text] [Related]
15. TAP1 and TAP2 polymorphism in HLA-B27-positive subpopulations: no allelic differences in ankylosing spondylitis and reactive arthritis.
Westman P; Partanen J; Leirisalo-Repo M; Koskimies S
Hum Immunol; 1995 Dec; 44(4):236-42. PubMed ID: 8770637
[TBL] [Abstract][Full Text] [Related]
16. Systematic approach demonstrates enrichment of multiple interactions between non-
Diaz-Gallo LM; Ramsköld D; Shchetynsky K; Folkersen L; Chemin K; Brynedal B; Uebe S; Okada Y; Alfredsson L; Klareskog L; Padyukov L
Ann Rheum Dis; 2018 Oct; 77(10):1454-1462. PubMed ID: 29967194
[TBL] [Abstract][Full Text] [Related]
17. [Serum anti-subtypical Klebsiella pneumoniae antibodies in ankylosing spondylitis].
Yuan G; Shi G; Ding Y
Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):193-5. PubMed ID: 7648943
[TBL] [Abstract][Full Text] [Related]
18. Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome.
Rosenbaum JT; Davey MP
Arthritis Rheum; 2011 Nov; 63(11):3195-8. PubMed ID: 21792826
[No Abstract] [Full Text] [Related]
19. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope.
Bang SY; Lee HS; Lee KW; Bae SC
J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323
[TBL] [Abstract][Full Text] [Related]
20. Coexisting ankylosing spondylitis and rheumatoid arthritis: a case report with literature review.
Guo YY; Yang LL; Cui HD; Zhao S; Zhang N
Chin Med J (Engl); 2011 Oct; 124(20):3430-2. PubMed ID: 22088550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
